Skip to main content
SpringerLink
Log in

Osteoporosis in lysinuric protein intolerance

  • Published:
Journal of Inherited Metabolic Disease

Summary

Lysinuric protein intolerance (LPI) is an autosomal recessive disease characterized by defective transport of cationic amino acids. Patients have an increased incidence of fractures and their skeletal radiographs show osteoporosis. The aim of the study was to characterize the osteopenia in LPI.

Twenty-nine Finnish LPI patients (age range 3.7–44.4 years) were screened for parameters of bone metabolism. Morphometric analysis of bone was carried out in specimens of 9 patients. Collagen synthesis was studied with cultured skin fibroblasts (4 patients) and collagen fibril sizes (3 patients) were measured using electron microscopy.

Most histological bone specimens (8/9) showed osteoporosis. Osteomalacia was excluded. Routine clinical laboratory tests were unrevealing. The concentrations of free hydroxyproline and type III procollagen N-propeptide in serum and the urinary excretion of hydroxyproline were increased in almost all patients during their growth and in about half of adult patients. Collagen synthesis in LPI fibroblast cultures was significantly decreased compared with that in age-matched controls at 5 (p<0.01), 14 (p<0.01) and still at 30 years (p<0.01), whereas no difference was observed at the age of 44 years (p=N.S.).

Osteoporosis in LPI might reflect defective matrix protein synthesis caused by protein deprivation and deficiency of cationic amino acids. Increased collagen turnover can also contribute to the osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bentsen KD, Henriksen JH, Bendtsen F, Horslev-Petersen K, Lorenzen I (1990) Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic liver disease.Hepatology 11: 957–963.

    Google Scholar 

  • Boskey AL (1990) Bone mineral and matrix.Orthop Clin N Am 21: 19–29.

    Google Scholar 

  • Brody LC, Mitchell GA, Obie C et al (1992) Ornithine delta-aminotransferase mutations in gyrate atrophy. Allelic heterogeneity and functional consequences.J Biol Chem 15: 3302–3307.

    Google Scholar 

  • Carpenter TO, Levy HL, Holtrop ME, Shih VE, Anast CS (1985) Lysinuric protein intolerance presenting as childhood osteoporosis.N Engl J Med 31: 290–294.

    Google Scholar 

  • Chen T (1977) In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.Exp Cell Res 104: 255–262.

    Google Scholar 

  • Consensus development conference: prophylaxis and treatment of osteoporosis. Conference report (1991)Am J Med 90: 107–110.

    Google Scholar 

  • Epstein S (1988) Serum and urinary markers of bone remodeling: assessment of bone turnover.Endocrine Rev 9: 437–449.

    Google Scholar 

  • Fouser L, Sage EH, Clark J, Bornstein P (1991) Feedback regulation of collagen gene expression: A Trojan horse approach.Proc Natl Acad Sci USA 88: 10158–10162.

    Google Scholar 

  • Gasser A, Celada A, Courvoisier B et al (1979) The clinical measurement of urinary total hydroxyproline excretion.Clin Chim Acta 95: 487–491.

    Google Scholar 

  • Gevers G, Dequeker J (1987) Collagen and non-collagenous protein content (osteocalcin, sialoprotein, proteoglycan) in the iliac crest bone and serum osteocalcin in women with and without hand osteoarthritis.Collagen Rel Res 7: 435–442.

    Google Scholar 

  • Hoikka V, Arnala I (1981) Histomorphometric normal values of the iliac crest cancellous bone in a Finnish autopsy series.Ann Clin Res 13: 383–386.

    Google Scholar 

  • Holbrook KA, Byers PM (1982) Structural abnormalities in the dermal collagen and elastic matrix from the skin of patients with inherited connective tissue disorders.J Invest Dermatol 79: 7–16.

    Google Scholar 

  • Jha GH, Deo MG, Ramalingaswami V (1968) Bone growth in protein deficiency, a study in rhesus monkeys.Am J Pathol 53: 1111–1121.

    Google Scholar 

  • Jimenez SA (1991) Molecular biological approaches to the study of heritable osteoarthritis.J Rheumatol 18: 7–9.

    Google Scholar 

  • Juva K, Prockop DJ (1966) Modified procedure for the assay of H3-or C14-labeled hydroxyproline.Anal Biochem 15: 77–83.

    Google Scholar 

  • Kuivaniemi H, Tromp G, Prockop DJ (1991) Mutations in collagen genes: Causes of rare and some common diseases in humans.F ASEB J 5: 2052–2060.

    Google Scholar 

  • Likins RC, Bavetta LA, Posner AS (1957) Calcification in lysine deficiency.Arch Biochem Biophys 70: 401–412.

    Google Scholar 

  • Melkko J, Niemi S, Risteli L, Risteli J (1990) Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.Clin Chem 36: 1328–1332.

    Google Scholar 

  • Minnisola S, Antonelli R, Mazzuoli G (1985) Clinical significance of free plasma hydroxyproline measurement in metabolic bone disease.J Clin Chem Clin Biochem 23: 515–519.

    Google Scholar 

  • Mizutani N, Kato T, Maehara M, Watanabe K, Ban M (1984) Oral administration of arginine and citrulline in the treatment of lysinuric protein intolerance.Tohuko J Exp Med 142: 15–24.

    Google Scholar 

  • Näntö-Salonen K, Penttinen R (1982) Metabolism of collagen in aspartylglycosaminuria: Decreased synthesis by cultured fibroblasts.J Inher Metab Dis 5: 197–203.

    Google Scholar 

  • Perheentupa J, Simell O (1974) Lysinuric protein intolerance.Birth Defects 10: 201–207.

    Google Scholar 

  • Pihlajaniemi T, Myllylä R, Kivirikko K (1991) Prolyl-4-hydroxylase and its role in collagen synthesis.J Hepatol 13 (Suppl.): 2–7.

    Google Scholar 

  • Prockop DJ, Kivirikko KJ (1984) Heritable diseases of collagen.N Engl J Med 9: 376–386.

    Google Scholar 

  • Rajantie J, Simell O, Rapola J, Perheentupa J (1980) Lysinuric protein intolerance: A two-year trial of dietary supplementation therapy with citrulline and lysine.J Pediatr 97: 927–932.

    Google Scholar 

  • Rajantie J, Simell O, Perheentupa J (1981) Lysinuric protein intolerance: basolateral transport defect in renal tubuli.J Clin Invest 67: 1078–1082.

    Google Scholar 

  • Rigotti N, Nussbaum S, Herzog D, Neer R (1984) Osteoporosis in women with anorexia nervosa.N Engl J Med 311: 1601–1606.

    Google Scholar 

  • Risteli L, Risteli J (1990) Noninvasive methods for detection of organ fibrosis. In Rojkind M, ed.Focus on Connective Tissue in Health and Disease. Boca Raton: CRC Press, 61–98.

    Google Scholar 

  • Robey PG (1989) The biochemistry of bone.Endocrin Metab N Am 18: 859–891.

    Google Scholar 

  • Shieres R, Avioli LV, Bergfeld MA, Fallon MD, Slatopolsky E, Teitelbaum SL (1980) Effects of semistarvation on skeletal homeostasis.Endocrinol 107: 1530–1535.

    Google Scholar 

  • Simell O (1989) Lysinuric protein intolerance and other cationic aminoacidurias. In Scriver C, Beaudet AL, Sly W and Valle D, eds.The Metabolic Basis of Inherited Disease, 6th edn. McGraw-Hill, New York, 2497–2513.

    Google Scholar 

  • Simell O, Perheentupa J, Rapola J, Visakorpi J, Eskelin L (1975) Lysinuric protein intolerance.Am J Med 59: 229–240.

    Google Scholar 

  • Smedsröd B (1988) Aminoterminal propeptide of type III procollagen is cleared from the circulation by receptor-mediated endocytosis in liver endothelial cells.Collagen Rel Res 8: 375–388.

    Google Scholar 

  • Svedström E, Parto K, Marttinen M, Virtama P, Simell O (1993) Skeletal manifestations of lysinuric protein intolerance. A follow-up study of 29 patients.Skeletal Radiol 22: 11–16.

    Google Scholar 

  • Trivedi P, Hindmarsh P, Risteli J, Risteli L, Mowat AP, Brook CGD (1989) Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen.J Pediatr 114: 225–230.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University Central Hospital, University of Turku, 20520, Turku, Finland

    K. Parto & O. Simell

  2. Department of Medical Biochemistry, University of Turku, 20520, Turku, Finland

    K. Parto & R. Penttinen

  3. Laboratory of Electron Microscopy, University of Turku, 20520, Turku, Finland

    L. Pelliniemi

  4. Department of Pathology, University of Tampere, 33520, Tampere, Finland

    I. Paronen

Authors
  1. K. Parto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Penttinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Paronen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Pelliniemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. O. Simell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parto, K., Penttinen, R., Paronen, I. et al. Osteoporosis in lysinuric protein intolerance. J Inherit Metab Dis 16, 441–450 (1993). https://doi.org/10.1007/BF00710296

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00710296

Keywords

Search

Navigation